Citiation Regenerative medicine
Articles published in Journal of Regenerative Medicine have been cited by esteemed scholars and scientists all around the world. Journal of Regenerative Medicine has got h-index 9, which means every article in Journal of Regenerative Medicine has got 9 average citations.
Following are the list of articles that have cited the articles published in Journal of Regenerative Medicine.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Year wise published articles |
30 | 31 | 20 | 32 | 5 | 9 |
Year wise citations received |
28 | 37 | 26 | 14 | 28 | 56 |
| Journal total citations count | 237 |
| Journal Impact Factor | 0.70 |
| Journal 5 years Impact Factor | 2.04 |
| Journal CiteScore | 1.83 |
| Journal h-index | 9 |
| Journal h-index since 2017 | 6 |
Sanjurjo-Rodríguez, C., Martínez-Sánchez, A. H., Hermida-Gómez, T., Fuentes-Boquete, I., Díaz-Prado, S., & Blanco, F. J. (2016). Differentiation of human mesenchymal stromal cells cultured on collagen sponges for cartilage repair. Histol Histopathol, 31(11), 1221-1239. |
Sanjurjo-Rodriguez, C., Castro-Vinuelas, R., Hermida-Gomez, T., Fernandez-Vazquez, T., Fuentes-Boquete, I. M., de Toro-Santos, F. J., ... & Blanco-García, F. J. (2017). Ovine mesenchymal stromal cells: morphologic, phenotypic and functional characterization for osteochondral tissue engineering. PLoS One, 12(1), e0171231. |
Aronowitz, J. A., Lockhart, R. A., Hakakian, C. S., & Birnbaum, Z. E. (2016). Adipose stromal vascular fraction isolation: A head-to-head comparison of 4 cell separation systems# 2. Annals of plastic surgery, 77(3), 354-362. |
Gonçalves, S. (2016). New therapeutic strategies for osteoarthritis: injective cell therapy (Doctoral dissertation). |
Young, B. K., Chan, M. K., Liu, L., & Basch, R. S. (2016). Amniotic fluid as a source of multipotent cells for clinical use. Journal of perinatal medicine, 44(3), 333-337. |
Dziadosz, M., Basch, R. S., & Young, B. K. (2016). Human amniotic fluid: a source of stem cells for possible therapeutic use. American journal of obstetrics and gynecology, 214(3), 321-327. |
KováÄ, M., KulÃková, B., VaÅ¡ÃÄek, J., & Chrenek, P. (2016). Cryopreservation of amniotic fluid stem cells derived from Zobor rabbit. Slovak Journal of Animal Science, 49(2), 62-67. |
Dziadosz, M., Chan, M., Basch, R., & Young, B. K. (2016). Effects of Pharmacological Agents on Human Amniotic Fluid-Derived Stem Cells in Culture. Stem Cells and Development, 25(20), 1570-1579. |
Ben-Arye, T., & Levenberg, S. (2019). Tissue engineering for clean meat production. Frontiers in Sustainable Food Systems, 3, 46. |
Esmaeli, A., Moshrefi, M., Shamsara, A., Eftekhar-vaghefi, S. H., & Nematollahi-mahani, S. N. (2016). Xeno-free culture condition for human bone marrow and umbilical cord matrix-derived mesenchymal stem/stromal cells using human umbilical cord blood serum. International Journal of Reproductive BioMedicine, 14(9), 567. |
Atkinson, P. J., Nicholson, M., & Richardson, R. T. Progressing towards a cure for deafness through gene therapy. |
Dimitropoulos, G., Jafari, P., de Buys Roessingh, A., Hirt-Burri, N., Raffoul, W., & LA1�µ, A. BURN PATIENT CARE LOST IN GOOD MANUFACTURING PRACTICES?. |
Sharma, A., Gokulchandran, N., Sane, H., Nagrajan, A., Paranjape, A., Kulkarni, P., ... & Badhe, P. (2013). Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem cells international, 2013. |
Bradstreet, J. J., Sych, N., Antonucci, N., Klunnik, M., Ivankova, O., Matyashchuk, I., ... & Siniscalco, D. (2014). Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study. Cell Transplantation, 23(1_suppl), 105-112. |
Siniscalco, D., Kannan, S., Semprún-Hernández, N., Eshraghi, A. A., Brigida, A. L., & Antonucci, N. (2018). Stem cell therapy in autism: recent insights. Stem cells and cloning: advances and applications, 11, 55. |
Siniscalco, D., & Antonucci, N. (2013). Possible use of Trichuris suis ova in autism spectrum disorders therapy. Medical Hypotheses, 81(1), 1-4. |
Khongrum, J., & Wattanathorn, J. (2015). Laser acupuncture improves behavioral disorders and brain oxidative stress status in the valproic acid rat model of autism. Journal of Acupuncture and Meridian Studies, 8(4), 183-191. |
Siniscalco, D., & Antonucci, N. (2013). Involvement of dietary bioactive proteins and peptides in autism spectrum disorders. Current Protein and Peptide Science, 14(8), 674-679. |
Sharma, A., Sane, H., Gokulchandran, N., Badhe, P., Patil, A., Kulkarni, P., & Paranjape, A. (2016). PET-CT scan shows decreased severity of autism after autologous cellular therapy: a case report. Autism Open Access, 6(169), 2. |
Siniscalco, D., & Antonucci, N. (2015). Nuclear Magnetic Resonance Spectroscopy in the Diagnosis of Autism-Related Disorders. In Applications of NMR Spectroscopy (pp. 131-142). Bentham Science Publishers. |
Sharma, A. K., Sane, H., Kulkarni, M. P., Gokulchandran, N., & Badhe, P. Cellular therapy in Neurodevelopmental disorders. brain injury, 6, 11. |
Siniscalco, D., & Antonucci, N. (2013). Role of Proteases in Autism Spectrum Disorders. In Proteases in Health and Disease (pp. 327-333). Springer, New York, NY. |
Brigida, A. L., & Siniscalco, D. (2016). Induced pluripotent stem cells as a cellular model for studying Down Syndrome. Journal of stem cells & regenerative medicine, 12(2), 54. |
Farrell, K., Joshi, J., & Kothapalli, C. R. (2017). Injectable uncrosslinked biomimetic hydrogels as candidate scaffolds for neural stem cell delivery. Journal of Biomedical Materials Research Part A, 105(3), 790-805. |
Jalili-Firoozinezhad, S., Mirakhori, F., & Baharvand, H. (2015). Nanotissue Engineering of Neural Cells. Stem Cell Nanoeng, 265, 265-283. |
Gupta, P., & Shetty, H. Research & Reviews: Journal of Pharmaceutics and Nanotechnology. |
Farrell, K. W. (2016). Role of Matrix Microenviroment on Neural Stem Cell Phenotype and Differentiation under Healthy and Inflammatory Conditions (Doctoral dissertation, Cleveland State University). |
Navarro, X., Torres-Espín, A., Allodi, I., Santos, D., González-Pérez, F., Udina, E., & del Valle, J. (2016). Analysis of axonal growth in organotypic neural cultures. |
Siniscalco, D., Bradstreet, J. J., Sych, N., & Antonucci, N. (2014). Mesenchymal stem cells in treating autism: Novel insights. World journal of stem cells, 6(2), 173. |
Sych, N., Klunnik, M., Ivankova, O., Matyaschuk, I., Demchuk, M., Novytska, A., ... & Siniscalco, D. (2014). Efficacy of fetal stem cells in Duchenne muscular dystrophy therapy. Journal of Neurorestoratology, 2(1), 37-46. |
Siniscalco, D., & Sych, N. (2015). Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies. Translational Neuroscience and Clinics, 1(2), 125-127. |
Parsons, X. H. (2013). Embedding the future of regenerative medicine into the open epigenomic landscape of pluripotent human embryonic stem cells. Annual research & review in biology, 3(4), 323. |
Parsons, X. H. (2013). Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell TherapyThe Turning Point of Cell-Based Regenerative Medicine. British biotechnology journal, 3(4), 424. |
Broccoli, V., Colasante, G., Sessa, A., & Rubio, A. (2015). Histone modifications controlling native and induced neural stem cell identity. Current opinion in genetics & development, 34, 95-101. |
Parsons, X. H. (2014). Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. In Human Embryonic Stem Cell Protocols (pp. 299-318). Humana Press, New York, NY. |
Ghosh, D., Mehta, N., Patil, A., & Sengupta, J. (2016). Ethical issues in biomedical use of human embryonic stem cells (hESCs). Journal of Reproductive Health and Medicine, 2, S37-S47. |
Parsons, X. H. (2013). Reviving cell-based regenerative medicine for heart reconstitution with efficiency in deriving cardiac elements from pluripotent human embryonic stem cells (Editorial). Cardiol Pharmacol, 2(3), e112. |
Parsons, X. H. (2013). Cellular medicine for the heart-the pharmacologic utility and capacity of human cardiac stem cells. J Clin Exp Cardiolog S, 11, 2. |
Parsons, X. H. (2013). Exploring future cardiovascular medicine: heart precursors directed from human embryonic stem cells for myocardium regeneration. Cardiovascular Pharmacology: Open Access. |
Parsons, X. H. (2014). The openness of pluripotent epigenome-Defining the genomic integrity of stemness for regenerative medicine. International Journal of Cancer Therapy and Oncology, 2(1). |
Parsons, X. H. (2014). The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol, 1(1), 2. |
Parsons, X. H. (2014). U.S. Patent No. 8,716,017. Washington, DC: U.S. Patent and Trademark Office. |
Parsons, X. H. (2013). Current state of regenerative medicine: moving stem cell research from animals into humans for clinical trials. Regen Med, 1(1), 1005. |
Yeh, D. C., & Chan, T. M. (2018). Therapeutics of Stem Cell Treatment in Anti-Aging and Rejuvenation. Stem Cell Discovery, 8(02), 13. |
Parsons, X. H. (2016). Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther, 1(1), 1-8. |
Parsons, X. H. (2016). Journal of Regenerative Therapeutics Volume 1, Issue 1, October 2016, Pages 18. Journal of Regenerative Therapeutics, 1(1), 1-8. |
Parsons, X. H. (2016). U.S. Patent No. 9,428,731. Washington, DC: U.S. Patent and Trademark Office. |
Parsons, X. H. (2016). U.S. Patent Application No. 14/520,990. |
Navarro, X., Torres-Espín, A., Allodi, I., Santos, D., González-Pérez, F., Udina, E., & del Valle, J. (2016). Analysis of axonal growth in organotypic neural cultures. |
Farfán, L. F. T. (2013). La reprogramación en la obtención de células madre pluripotentes inducidas. ECIPeru: Revista del Encuentro Científico Internacional, 10(1), 9-13. |
Farfán, L. F. T. (2013). La reprogramación en la obtención de células madre pluripotentes inducidas Reprogramming in obtaining induced pluripotent stem cells. Revista ECIPerú Volumen, 10(1). |
Srivastava, A., Dadheech, N., Vakani, M., & Gupta, S. (2018). Swertisin ameliorates diabetes by triggering pancreatic progenitors for islet neogenesis in Streptozotocin treated BALB/c mice. Biomedicine & Pharmacotherapy, 100, 221-225. |
Thakur, G., Lee, H. J., Jeon, R. H., Lee, S. L., & Rho, G. J. (2020). Small Molecule-Induced Pancreatic ?-Like Cell Development: Mechanistic Approaches and Available Strategies. International journal of molecular sciences, 21(7), 2388. |
Srivastava, A., Dadheech, N., Vakani, M., & Gupta, S. (2019). Pancreatic resident endocrine progenitors demonstrate high islet neogenic fidelity and committed homing towards diabetic mice pancreas. Journal of cellular physiology, 234(6), 8975-8987. |
Sassoli, C., Nosi, D., Tani, A., Chellini, F., Mazzanti, B., Quercioli, F., ... & Formigli, L. (2014). Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells. Experimental Cell Research, 323(2), 297-313. |
Sassoli, C., Frati, A., Tani, A., Anderloni, G., Pierucci, F., Matteini, F., ... & Meacci, E. (2014). Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation. PLoS One, 9(9), e108662. |
Sassoli, C., Zecchi-Orlandini, S., Bani, D., & Formigli, L. (2013). Cardiac progenitor cells as target of cell and growth factor-based therapies for myocardial regeneration. J. Stem Cell Res. Ther, 9(004). |
Scott, C. M., Forster, C. L., & Kokkoli, E. (2015). Three-dimensional cell entrapment as a function of the weight percent of peptide-amphiphile hydrogels. Langmuir, 31(22), 6122-6129. |
Scott, C. M. (2016). Peptide-functionalized hydrogels for three-dimensional cell culture (Doctoral dissertation, University of Minnesota). |
POOK, T. MARTIN POOK. |
Menaa, F., Abdelghani, A., & Menaa, B. (2015). Graphene nanomaterials as biocompatible and conductive scaffolds for stem cells: impact for tissue engineering and regenerative medicine. Journal of tissue engineering and regenerative medicine, 9(12), 1321-1338. |
Kim, T. H., Lee, T., El-Said, W. A., & Choi, J. W. (2015). Graphene-based materials for stem cell applications. Materials, 8(12), 8674-8690. |
Shahrokhi, S., Daneshmandi, S., & Menaa, F. (2014). Tumor necrosis factor-?/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice. Human gene therapy, 25(3), 240-253. |
Martins, O., Matos, S., Figueiredo, M. H., Viegas, C., & Dias, I. (2014). Novel Nanocrystalline Hydroxyapatite for Bone Regeneration. J Regen Med 3: 1. of, 7, 14-17. |
Liu, M., Huang, F., Zhang, D., Ju, J., Wu, X. B., Wang, Y., ... & Zhao, Q. (2015). Heterochromatin protein HP1? promotes colorectal cancer progression and is regulated by miR-30a. Cancer research, 75(21), 4593-4604. |
Zhang, Y., Mignone, J., & MacLellan, W. R. (2015). Cardiac regeneration and stem cells. Physiological reviews, 95(4), 1189-1204. |
Gabisonia, K., & Recchia, F. A. (2018). Gene therapy for heart failure: new perspectives. Current heart failure reports, 15(6), 340-349. |
Piccoli, M. T., Gupta, S. K., & Thum, T. (2015). Noncoding RNAs as regulators of cardiomyocyte proliferation and death. Journal of molecular and cellular cardiology, 89, 59-67. |
Ponnusamy, M., Li, P. F., & Wang, K. (2017). Understanding cardiomyocyte proliferation: an insight into cell cycle activity. Cellular and Molecular Life Sciences, 74(6), 1019-1034. |
Liu, H., Zhang, Z., Wu, N., Guo, H., Zhang, H., Fan, D., ... & Liu, Y. (2018). Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals functional lncRNAs in gastric cancer. Genes, 9(6), 303. |
Yuan, X., & Braun, T. (2017). Multimodal regulation of cardiac myocyte proliferation. Circulation research, 121(3), 293-309. |
Hu, E., Ding, L., Miao, H., Liu, F., Liu, D., Dou, H., & Hou, Y. (2015). MiR-30a attenuates immunosuppressive functions of IL-1?-elicited mesenchymal stem cells via targeting TAB3. FEBS letters, 589(24), 3899-3907. |
Sommese, L., Zullo, A., Schiano, C., Mancini, F. P., & Napoli, C. (2017). Possible muscle repair in the human cardiovascular system. Stem cell reviews and reports, 13(2), 170-191. |
Braga, L., Ali, H., Secco, I., & Giacca, M. (2021). Non-coding RNA therapeutics for cardiac regeneration. Cardiovascular research, 117(3), 674-693. |
Xiao, J., Liu, H., Cretoiu, D., Toader, D. O., Suciu, N., Shi, J., ... & Li, X. (2017). miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1. Experimental & molecular medicine, 49(10), e386-e386. |
Raso, A., & Dirkx, E. (2017). Cardiac regenerative medicine: at the crossroad of microRNA function and biotechnology. Non-coding RNA research, 2(1), 27-37. |
Sadiq, S., Crowley, T. M., Charchar, F. J., Sanigorski, A., & Lewandowski, P. A. (2017). Micro RNA s in a hypertrophic heart: from foetal life to adulthood. Biological Reviews, 92(3), 1314-1331. |
Soler-Botija, C., Forcales, S. V., & Genís, A. B. (2020, January). Spotlight on epigenetic reprogramming in cardiac regeneration. In Seminars in cell & developmental biology (Vol. 97, pp. 26-37). Academic Press. |
Wu, L., Yang, K., Gui, Y., & Wang, X. (2020). Nicotine-upregulated miR-30a arrests cell cycle in G1 phase by directly targeting CCNE2 in human periodontal ligament cells. Biochemistry and Cell Biology, 98(3), 354-361. |
Dong, X., Dong, X., Gao, F., Liu, N., Liang, T., Zhang, F., ... & Chen, J. (2021). Non?coding RNAs in cardiomyocyte proliferation and cardiac regeneration: Dissecting their therapeutic values. Journal of Cellular and Molecular Medicine, 25(5), 2315-2332. |
Yeh, D. C., & Chan, T. M. (2018). Therapeutics of Stem Cell Treatment in Anti-Aging and Rejuvenation. Stem Cell Discovery, 8(02), 13. |
MACLELLAN, W. R., & Danny, E. N. (2016). |
Raso, A., & Dirkx, E. (2017). Non-coding RNA Research. |
Bongiovanni, C., Sacchi, F., Da Pra, S., Pantano, E., Miano, C., Morelli, M. B., & D'Uva, G. (2021). Reawakening the Intrinsic Cardiac Regenerative Potential: Molecular Strategies to Boost Dedifferentiation and Proliferation of Endogenous Cardiomyocytes. Frontiers in Cardiovascular Medicine, 1283. |
Yang Qian, Gui Yonghao, & Li Qiang. (2016). MicroRNA regulation of DNA methylation in congenital heart disease and its application prospects. Chinese Journal of Pathophysiology , 32 (11), 2101-2105. |
Akane Sakaguchi, & Ko Kimura. (2018). Elucidation of cardiomyocyte proliferation control mechanism. Heart , 50 (12), 1276-1282. |
Sych, N. S., Ivankova, O. V., Klunnyk, M. O., Matiyashchuk, I. G., Sinelnyk, A. A., Demchyk, M. P., ... & Siniscalco, D. (2015). Fetal stem cells are effective in the treatment of Grade I and II respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy. Translational Neuroscience and Clinics, 1(1), 10-16. |
Dutta, R. C., & Dutta, A. K. (2018). 3D Cell Culture: Fundamentals and Applications in Tissue Engineering and Regenerative Medicine. CRC Press. |
Pantelic, M. N., & Larkin, L. M. (2018). Stem cells for skeletal muscle tissue engineering. Tissue Engineering Part B: Reviews, 24(5), 373-391. |
Sarrafian, T. L., Bodine, S. C., Murphy, B., Grayson, J. K., & Stover, S. M. (2018). Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review. Veterinary Surgery, 47(4), 524-535. |
Iannotti, F. A., Pagano, E., Guardiola, O., Adinolfi, S., Saccone, V., Consalvi, S., ... & Di Marzo, V. (2018). Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy. Nature communications, 9(1), 1-13. |
Sohn, J., Lin, H., Fritch, M. R., & Tuan, R. S. (2018). Influence of cholesterol/caveolin-1/caveolae homeostasis on membrane properties and substrate adhesion characteristics of adult human mesenchymal stem cells. Stem cell research & therapy, 9(1), 1-15. |
Oh, S., Jung, S. H., Seo, H., Min, M. K., Kim, B., Hahn, Y. K., ... & Choi, S. (2018). Magnetic activated cell sorting (MACS) pipette tip for immunomagnetic bacteria separation. Sensors and Actuators B: Chemical, 272, 324-330. |
Syverud, B. C., Lin, E., Nagrath, S., & Larkin, L. M. (2018). Label-free, high-throughput purification of satellite cells using microfluidic inertial separation. Tissue Engineering Part C: Methods, 24(1), 32-41. |
Fish, K. D., Rubio, N. R., Stout, A. J., Yuen, J. S., & Kaplan, D. L. (2020). Prospects and challenges for cell-cultured fat as a novel food ingredient. Trends in food science & technology, 98, 53-67. |
Rodriguez, B. L., Nguyen, M. H., Armstrong, R. E., Vega-Soto, E. E., Polkowski, P. M., & Larkin, L. M. (2020). A comparison of ovine facial and limb muscle as a primary cell source for engineered skeletal muscle. Tissue Engineering Part A, 26(3-4), 167-177. |
Li, L., Liu, G., Timashev, P., Sun, X. S., Criswell, T., Atala, A., & Zhang, Y. (2019). Biofabrication of tissue-specific extracellular matrix proteins to enhance the expansion and differentiation of skeletal muscle progenitor cells. Applied Physics Reviews, 6(2), 021309. |
Careccia, G., Colombo, F., Tirone, M., Agresti, A., Bianchi, M. E., Zambrano, S., & Vénéreau, E. (2019). Exploiting live imaging to track nuclei during myoblast differentiation and fusion. JoVE (Journal of Visualized Experiments), (146), e58888. |
Lin, E. (2017). High throughput microfluidic labyrinth for the label free isolation of CTCs for single cell gene expression profiling (Doctoral dissertation). |
Yeh, D. C., & Chan, T. M. (2018). Therapeutics of Stem Cell Treatment in Anti-Aging and Rejuvenation. Stem Cell Discovery, 8(02), 13. |